Dr. Stephan Grupp, MD
Claim this profileChildren's Hospital of Philadelphia
Area of expertise
Leukemia
Stephan Grupp, MD has run 5 trials for Leukemia. Some of their research focus areas include:
Acute Lymphoblastic Leukemia
Stephan Grupp, MD has run 2 trials for Acute Lymphoblastic Leukemia.
Affiliated Hospitals
Children's Hospital Of Philadelphia
The Children's Hospital Of Philadelphia (CHOP)
Clinical Trials Stephan Grupp, MD is currently running
Long-Term Follow-Up
for CAR-T Therapy Safety
Per Health Authorities guidelines for gene therapy medicinal products that utilize integrating vectors (e.g. lentiviral vectors), long term safety and efficacy follow up of treated patients is required. The purpose of this study is to monitor all patients exposed to CAR-T therapied for 15 years following their last CAR-T (e.g. CTL019) infusion to assess the risk of delayed adverse events (AEs), monitor for replication competent lentivirus (RCL) and assess long-term efficacy, including vector persistence.
Recruiting
2 awards
Phase 3
2 criteria
Stem Cell Transplant
for Bone Marrow Failure Syndrome
The goal of this protocol is to expand access for patients who lack a fully HLA (Human leukocyte antigen) matched sibling donor and who are candidates for allogeneic hematopoietic stem cell transplant (HSCT). These patients have a serious or immediately life-threatening disease for which HSCT is indicated. These patients are not eligible for other Children's Hospital of Philadelphia IRB approved protocols that utilize CliniMACs technology for T depletion.
Recruiting
1 award
Phase < 1
6 criteria
More about Stephan Grupp, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Stephan Grupp, MD has experience with
- CART22 Cells
- Prednisone
- Tisagenlecleucel
- CAR-T
- CTL019
- CliniMACs
Breakdown of trials Stephan Grupp, MD has run
Leukemia
Acute Lymphoblastic Leukemia
Lymphoma
Bone Marrow Failure Syndrome
B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephan Grupp, MD specialize in?
Stephan Grupp, MD focuses on Leukemia and Acute Lymphoblastic Leukemia. In particular, much of their work with Leukemia has involved CD22 positive patients, or patients who are HLA negative.
Is Stephan Grupp, MD currently recruiting for clinical trials?
Yes, Stephan Grupp, MD is currently recruiting for 2 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Stephan Grupp, MD has studied deeply?
Yes, Stephan Grupp, MD has studied treatments such as CART22 cells, Prednisone, Tisagenlecleucel.
What is the best way to schedule an appointment with Stephan Grupp, MD?
Apply for one of the trials that Stephan Grupp, MD is conducting.
What is the office address of Stephan Grupp, MD?
The office of Stephan Grupp, MD is located at: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the Children's Hospital of Philadelphia.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.